Internalin A is a surface protein of the facultative intracellular pathogen Listeria monocytogenes that interacts with the human host cell protein E-cadherin to facilitate invasion of epithelial cells. A single amino acid substitution at position 16 in mouse E-cadherin prevents this interaction. Synthetic polypeptides of 30 aa encompassing position 16 of human and mouse E-cadherin were tested for their ability to inhibit in vitro invasion of Caco-2, HepG2 and TIB73 cell lines by L. monocytogenes. Only the human-derived peptide was capable of inhibiting invasion in the humanorigin Caco-2 and HepG2 cell lines. These findings demonstrate that small polypeptides can inhibit invasion of biologically relevant cell types by L. monocytogenes in vitro and may be potentially useful as therapeutic agents in vivo.
INTRODUCTION
As a facultative intracellular pathogen, Listeria monocytogenes is dependent upon the ability to invade and survive within host cells. In the case of human epithelial cells, invasion is mediated by interaction of the L. monocytogenes virulence protein internalin A (InlA) with E-cadherin, a transmembrane cell adhesion glycoprotein expressed on the surface of epithelial cells and other cell types (Lebrun et al., 1996; Mengaud et al., 1996a) . The role that InlA plays in invasion of liver and other tissues is less clear. InlB, a closely related Listeria protein also containing leucine-rich repeat domains, is encoded within the same operon as inlA and may play a role in invasion of non-epithelial cells (Dramsi et al., 1995; Khelef et al., 2006; Pizarro-Cerda & Cossart, 2006) . Polymorphic variations and mutations in InlA significantly alter the virulence potential of L. monocytogenes isolates (Nightingale et al., 2005) . A series of Ecadherin chimeras was developed, which identified the first extracellular domain as the portion of the molecule specifically interacting with InlA (Lecuit et al., 1999) . Whilst E-cadherin is evolutionarily conserved, speciesspecific polymorphisms exist that greatly affect the interaction with InlA and infectivity. A specific amino acid substitution in mouse E-cadherin has been associated with reduced oral infectivity in the mouse model compared with the guinea pig (Lecuit et al., 2001) . This single amino acid substitution of glutamic acid for proline at residue 16 renders mouse and rat E-cadherin ineffective as a ligand for InlA (Lecuit et al., 1999) , as demonstrated using an in vitro model of cell invasion in which several cell lines expressing the mouse version of E-cadherin were uniformly refractory to L. moncytogenes invasion. Interference with the interaction of InlA and human E-cadherin has been shown to inhibit invasion of human epithelial cell lines. Antibodies specific for the leucine-rich repeat region of E-cadherin inhibit invasion (Mengaud et al., 1996b) . Supernatants from cultures of the Kato III human gastric cancer cell line secrete a truncated 25 kDa fragment of the N-terminal domain of E-cadherin that strongly inhibits invasion of Caco-2 cells (da Silva Tatley et al., 2003) . These results led us to investigate whether a synthetic polypeptide based on the region of human E-cadherin critical for binding InlA could inhibit cellular invasion by L. monocytogenes strains.
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On: Wed, 23 Jan 2019 18:36:49 into Scott A and 12443 cells using a Gene Pulser II (Bio-Rad) with previously described conditions and settings (Alexander et al., 1990) . The transformed cells were selected on brain heart infusion (BHI) agar containing 15 mg erythromycin ml
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. After 24 h of growth, colonies were examined under long-wave UV light for GFP expression. Several of the most fluorescent colonies were selected, expanded in broth culture containing erythromycin and analysed by flow cytometry for GFP intensity. Isolates with the greatest fluorescence intensity were frozen in 50 % glycerol and used for invasion experiments.
Cellular invasion assays. For invasion studies testing the effects of E-cadherin peptides, HPLC-purified peptides were dissolved in Hanks' balanced salt solution (HBSS; Invitrogen). GFP-labelled L. monocytogenes strains were grown for 18 h in BHI broth in the presence of erythromycin, washed three times in HBSS and standardized at an OD 550 of 0.5. Bacteria were then pelleted by centrifugation and resuspended in the same volume of RPMI 1640 (Invitrogen) without antibiotics and supplemented with 10 % fetal bovine serum (FBS) in the presence of the indicated final concentration of peptide for 1 h prior to addition to eukaryotic cells. Caco-2 human epithelial cells, HepG2 human hepatocytes and TIB73 mouse hepatocytes (ATCC) were seeded into 24-well cell culture plates (Costar) at a concentration of 2610 5 cells per well, 24 h prior to the addition of bacteria. Seeding the wells under these conditions routinely resulted in confluent monolayers after 24 h of growth. Cell wells were washed three times with antibiotic-free RPMI 1640 containing FBS and the bacteria/peptide suspension was added. Invasion was allowed to proceed for 1 h at 37 uC in 5 % CO 2. After invasion, the cells were washed three times with antibiotic-free medium, followed by the addition of RPMI 1640 containing FBS and 10 mg gentamicin (Invitrogen) ml
. After 1 h of exposure to gentamicin, the level of cell invasion was determined by washing the cells with HBSS, followed by lysis with 1 ml 0.1 % Triton X-100 (Sigma) and plating of the cell lysate on tryptic soy agar (TSA). This time point was referred to as the baseline. Additional cells were assayed at 24 h to measure intracellular replication of bacteria. All invasion assays were performed in six replicate wells. To calculate invasion and replication, the c.f.u. count, based on the mean of duplicate TSA plates, from four replicate wells was averaged. Statistical comparisons were made between the mean c.f.u. of the four replicate wells using t-test analyses. Intact cells from the two additional replicate wells were harvested by treatment with trypsin/ EDTA solution and used for determination of cell invasion by flow cytometric analysis of GFP-labelled Listeria cell invasion.
Flow cytometry. Caco-2 and HepG2 cells infected with GFP-labelled Listeria were analysed for infection by flow cytometry using a FACSVantage SE flow cytometer (Becton Dickinson) as described previously (Raybourne & Bunning 1994; Xie et al., 2003) . Briefly, the viable cell population was gated based on forward versus 90u light scatter parameters and the green fluorescence intensity of the gated population was used to identify L. monocytogenes-infected cells.
Statistical analysis. The mean c.f.u. per well was compared among four replicate wells of each treatment by analysis of variance. Tukey's studentized range test was used to compare mouse and human Ecadherin peptides and Dunnett's t-test was used to compare both Ecadherin peptides with controls (no peptide).
RESULTS AND DISCUSSION

Inhibition of invasion in Caco-2 cells
Experiments testing the ability of E-cadherin peptides to inhibit invasion of Caco-2 cells were repeated three times with similar results. Representative data are shown in Fig.1 . Flow cytometry of baseline samples indicated that exposure to the human E-cadherin peptide resulted in a large reduction in the percentage of Caco-2 cells that were positive for GFP-labelled Listeria compared with the results from Caco-2 cells exposed to the mouse E-cadherin peptide, which was similar to the control with no peptide (Fig. 1a) . This effect was concentration-dependent, with 100 mg peptide ml 21 showing a 99 % inhibition of invasion, whereas 10 mg ml 21 resulted in approximately 50 % inhibition. Results of colony counts (c.f.u.) paralleled this finding but were somewhat less sensitive in demonstrating the inhibitory effect of the lower concentration of human E-cadherin peptide. An approximate 10-fold reduction in c.f.u. was seen at the higher concentration, and there was a distinct dose effect on invasion, as measured by c.f.u., using the lower concentration of peptide. Statistically, both concentrations of human peptide were significantly different from the control (P ,0.05), whereas neither concentration of the mouse peptide was different from the control. The mouse and human peptides were significantly different from each other at both concentrations. Increasing the concentration of human E-cadherin peptide to 500 mg ml 21 did not result in further inhibition of invasion (data not shown). At 24 h, there was an approximate 100-fold increase in the number of Listeria c.f.u. However, the relative difference between the human E-cadherin peptide and the other groups was maintained. Flow cytometry results at 24 h demonstrated that over 90 % of Caco-2 cells in all groups except the highest concentration of human E-cadherin peptide had become infected as a result of cell-to-cell spread of L. monocytogenes between confluent cells (Portnoy et al., 2002) (Fig. 1b) . Whilst there was also a greater than 10-fold increase in the percentage of infected cells after 24 h following treatment with the higher concentration of human E-cadherin peptide, the effects of inhibition of invasion by the peptide were still evident. These findings were replicated and extended to a primate isolate of L. monocytogenes, strain 12443, which is a different serotype (1/2a) (Table 1) . These results also showed that, whilst there was replication (fold increase) of L. monocytogenes at 24 h in all groups, there was reduced replication in the human-derived peptide groups indicating a residual effect at 24 h. Statistical analysis of the invasion data at baseline again demonstrated a significant difference between the human and mouse peptides. As expected, statistical analysis indicated a significant difference between the control and human peptide-treated wells for both strains of L. monocytogenes. A small but statistically significant difference was also seen between the 
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control and mouse peptide with strain Scott A, but not with strain 12443. It should be noted, however, that the magnitude of difference between the mouse peptide and control, whilst statistically different, was very small relative to the human peptide and may be of questionable biological significance in the outcome of the in vitro infection. This effect with mouse-derived peptide occurred in one of four experiments involving human cell lines and may reflect a non-specific effect of peptide treatment or a weak interaction between the mouse peptide and the bacteria. The more important trend was that mouse and human peptides were significantly different in all experiments with human cell lines.
Inhibition of invasion in hepatocytes
To address the cellular specificity of the peptide inhibition of invasion, similar experiments were carried out with TIB73 mouse hepatocytes and the human hepatocyte line HepG2. Neither mouse nor human E-cadherin peptide influenced invasion of the mouse cell line by L. monocytogenes to the degree seen with Caco-2 and the human-derived peptide (Table 2) . Statistically small but significant differences were seen with both the mouse and human peptides when compared with the control with no peptide; however, there was no difference between the mouse-and human-derived peptides. With HepG2 human hepatocytes, there was a higher degree of invasion than was seen with the Caco-2 intestinal cell line at an equivalent m.o.i. and an approximate sixfold inhibition of invasion with the human Ecadherin peptide (Table 3) . As expected, the efficiency of invasion was greatly increased in human hepatocytes compared with mouse. Flow cytometry confirmed this observation (data not shown). Statistically significant differences were seen between the human peptide and control and between the mouse and human peptides. These results indicated that the invasion process may be more efficient in HepG2 cells than in the Caco-2 human intestinal cell line. This may be relevant to infection in vivo, as the liver is a site of replication in systemic listeriosis (Gregory et al., 1992) .
Expression of E-cadherin on Caco-2 and HepG2 cells
As peptide inhibition of invasion is assumed to be specific for the InlA-E-cadherin interaction, we investigated expression of E-cadherin on adherent HepG2 and Caco-2 cells, as trypsin treatment to detach adherent cells can affect E-cadherin. HepG2 and Caco-2 cells attached to four-well glass culture slides (BD Biosciences) were stained with a phycoerythrin-conjugated monoclonal antibody specific for human E-cadherin (1 mg ml
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; R&D Systems) and examined by laser-scanning cytometry (CompuCyte). Controls for non-specific binding of the antibody were Fc receptor blocking with normal human IgG and a phycoerythrin-conjugated isotype control antibody. Both cell lines were equally positive for E-cadherin (Fig. 2) , indicating that increased E-cadherin expression was not the basis of increased invasion efficiency in HepG2 cells. The increased efficiency of invasion in hepatocytes may be a reflection of synergism between InlA and InlB, which is involved in invasion of hepatocytes and a number of other cell types. The inlB gene is contained within the same operon as inlA and may be co-transcribed with inlA under the control of the prfA transcriptional regulator (Lingnau et al., 1995) . InlB mediates invasion by co-opting host cell signalling pathways via interaction with the hepatocyte growth factor receptor Met, which is found on a large number of cell types (Shen et al., 2000) . A cell invasion study using inlA and inlB gene deletion mutants and the same cell lines used in this study demonstrated that InlB alone mediated invasion of mouse hepatocytes, and that both InlA and InlB were required for human hepatocyte invasion (Dramsi et al., 1995) . Our results support this observation, as specific interference with InlA by the human E-cadherin peptide strongly inhibited human hepatocyte invasion, but the invasion of mouse hepatocytes was not affected to a similar extent.
Our results indicate that a relatively small peptide of approximately 3.5 kDa can effectively inhibit invasion of human enterocyte and hepatocyte cell lines. In addition to invasion inhibition by Kato III cell culture supernatants, it has been demonstrated that a recombinant human Ecadherin 25 kDa peptide inhibited invasion of Caco-2 cells by L. monocytogenes and that a mutant version of this peptide with a proline to glutamate substitution at position 16 was ineffective at inhibiting invasion (da Silva Tatley et al., 2003) . Our results support and extend these findings by demonstrating that a synthetic polypeptide of about one-seventh of this molecular mass can inhibit Caco-2 cell invasion. In addition, flow cytometric analysis using GFPlabelled L. monocytogenes provided independent direct evidence for inhibition of invasion. We also followed the infection for 24 h and demonstrated the residual effects of the human-derived peptide. The degree of inhibition achieved with the synthetic peptide appeared to be equivalent to or greater than that seen with the Kato III supernatants or the 25 kDa recombinant truncated human E-cadherin protein (da Silva Tatley et al., 2003) , indicating that the smaller synthetic peptide is capable of interfering efficiently with the receptor-ligand interaction between InlA and E-cadherin on host cells. It further suggests that the interaction with InlA may not involve tertiary conformational structure on the part of E-cadherin. It does not exclude a potential role for formation of multimers of the peptide as a result of interpeptide disulfide bonds, as there is a single cysteine in both the human and mouse peptides. As synthetic polypeptides can easily be produced and purified in relatively large amounts, they may provide a useful tool to study the mechanisms involved in InlA-mediated host cell invasion. In addition, the ability of the peptide to inhibit invasion in cell types such as hepatocytes that involve InlB and InlA raises the possibility that it could be a useful novel therapeutic agent to modify systemic infection.
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Orange integral Fig. 2 . Immunofluorescent staining of Caco-2 and HepG2 cells with phycoerythrin-labelled anti-human E-cadherin monoclonal antibody (line histograms). The x-axis represents fluorescence intensity (log scale). The solid histograms are isotype control staining with phycoerythrin-labelled mouse IgG2.
